Metoprolol Succinate Extended Release Tablets

Valsts: Jaunzēlande

Valoda: angļu

Klimata pārmaiņas: Medsafe (Medicines Safety Authority)

Aktīvā sastāvdaļa:

Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg

Pieejams no:

AFT Pharmaceuticals Ltd

SNN (starptautisko nepatentēto nosaukumu):

Metoprolol succinate 23.75 mg (equivalent to metoprolol tartrate 25mg)

Deva:

23.75 mg

Zāļu forma:

Modified release tablet

Kompozīcija:

Active: Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg Excipient: Cellulose acetate Crospovidone Glyceryl monostearate Hypromellose Methacrylic acid copolymer Microcrystalline cellulose Opadry clear YS-1-7006 Opadry white YS-1-7003 Poloxamer 188 Polysorbate 80 Sugar spheres

Receptes veids:

Prescription

Ražojis:

Watson Pharma Private Limited

Ārstēšanas norādes:

Metoprolol Succinate Extended-Release Tablets are indicated for the treatment of: Hypertension - to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

Produktu pārskats:

Package - Contents - Shelf Life: Bottle, plastic, HDPE bottle with PP cap - 100 tablets - 36 months from date of manufacture stored at or below 25°C

Autorizācija datums:

2016-06-24